| Literature DB >> 33921530 |
Jinho Bae1, Yujin Song1, Mohammad Moniruzzaman2, Ali Hamidoghli1, Seunghan Lee3, Hyeongwoo Je1, Wonsuk Choi1, Taesun Min2, Sungchul C Bai1,4.
Abstract
We performed an 8-week feeding trial to evaluate dietary soluble extract hydrolysates from fishery by-products, such as shrimp soluble extract (SSE) with or without inosine monophosphate (IMP), tilapia soluble extract (TSE) and squid soluble extract (SQSE), in juvenile Nile tilapia. A diet without feed additives was used as the control diet (CON); and five other experimental diets were formulated with 2% soluble extracts consisting of 100% SSE, 98% SSE + 2% IMP (SSEP2), 96% SSE + 4% IMP (SSEP4), 100% SQSE and 100% TSE. The diets were fed to 4.9 ± 0.07 g (mean ± SD) juvenile Nile tilapia in triplicate groups. The weight gain and specific growth rates of fish fed the SSE, SSEP2 and SSEP4 diets were significantly higher than those of fish fed the CON and SQSE diets. The superoxide dismutase activity levels of fish fed the SSE and SSEP4 diets were significantly higher than those of fish fed the CON, SSEP2, SQSE and TSE diets. Myeloperoxidase activity levels of fish fed the SSE and SSEP4 diets were significantly higher than those of fish fed the CON, SSEP2 and SQSE diets. Lysozyme activity levels of fish fed the SSEP4 and SQSE diets were significantly higher than those of fish fed the SSE and SSEP2 diets. Feed efficiency, protein efficiency ratio, survival rate, whole body proximate composition and hematological parameters were not significantly different among the groups. After ten days of challenge = against Aeromonas hydrophila, the cumulative survival rate of fish fed the SSE diet was significantly higher than those of fish fed the CON, SQSE and TSE diets. In conclusion, dietary shrimp soluble extract could improve the growth performance, non-specific immune responses and disease resistance in juvenile Nile tilapia, and inosine monophosphate did not add further benefits to this ingredient.Entities:
Keywords: Nile tilapia; disease resistance; fishery by-products; growth performance; hematology; inosine monophosphate; non-specific immune responses
Year: 2021 PMID: 33921530 PMCID: PMC8070139 DOI: 10.3390/ani11041107
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Formulations and proximate compositions of six experimental diets (percentages of dry matter basis).
| Ingredients | Diets | |||||
|---|---|---|---|---|---|---|
| CON | SSE | SSEP2 | SSEP4 | SQSE | TSE | |
| Fishmeal (Tuna) 1 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
| Soybean meal 1 | 34.60 | 34.00 | 34.00 | 34.00 | 34.00 | 34.00 |
| Wheat flour 1 | 34.99 | 33.54 | 33.54 | 33.54 | 33.54 | 33.54 |
| Rapeseed meal 1 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Meat and bone meal 1 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Poultry offal meal 1 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Squid liver meal 1 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Soybean oil 1 | 1.30 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 |
| Fish oil 2 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Other 3 | 3.11 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 |
| SSE 4 | 2.00 | |||||
| SSE + IMP 5 2% | 2.00 | |||||
| SSE + IMP 4% | 2.00 | |||||
| SQSE 6 | 2.00 | |||||
| TSE 7 | 2.00 | |||||
| Total | 100 | 100 | 100 | 100 | 100 | 100 |
|
| ||||||
| Moisture | 9.42 | 9.90 | 9.84 | 9.22 | 9.82 | 9.08 |
| Crude protein | 33.32 | 32.64 | 32.90 | 33.25 | 32.40 | 32.33 |
| Crude lipid | 5.20 | 5.79 | 5.78 | 5.41 | 5.92 | 6.22 |
| Crude ash | 8.02 | 8.08 | 8.08 | 8.28 | 8.16 | 8.36 |
1 CJ Ceiljedang Co. Seoul, Korea. 2 The feed Co. Goyang, Korea. 3 Other: Mineral premix, vitamin premix, protide (nucleotide by-product) and protease (CJ Ceiljedang Co.). 4 SSE: Shrimp soluble extract. 5 IMP: Inosine monophosphate; 6 SQSE: Squid soluble extract. 7 TSE: Tilapia soluble extract.
Growth performances of juvenile Nile tilapia fed six experimental diets for eight weeks 1.
| Diets | ||||||
|---|---|---|---|---|---|---|
| CON | SSE | SSEP2 | SSEP4 | SQSE | TSE | |
| WG 2 | 254.01 ± 3.57 b | 264.24 ± 2.71 a | 264.71 ± 4.67 a | 264.95 ± 2.87 a | 253.49 ± 5.32 b | 256.84 ± 4.13 ab |
| SGR 3 | 2.63 ± 0.02 b | 2.69 ± 0.02 a | 2.70 ± 0.03 a | 2.70 ± 0.02 a | 2.63 ± 0.03 b | 2.65 ± 0.02 ab |
| FE 4 | 76.90 ± 0.93 ns | 71.41 ± 1.79 | 75.04 ± 3.66 | 74.21 ± 1.58 | 72.91 ± 2.19 | 72.62 ± 4.07 |
| FI 5 | 354.70 ± 7.52 b | 397.20 ± 9.12 a | 380.60 ± 5.03 ab | 384.70 ± 7.05 a | 373.40 ± 6.12 ab | 377.80 ± 8.50 ab |
| PER 6 | 2.09 ± 0.03 ns | 1.97 ± 0.05 | 2.06 ± 0.10 | 2.03 ± 0.04 | 2.03 ± 0.06 | 2.04 ± 0.11 |
| Survival 7 | 100.00 ± 0.00 ns | 100.00 ± 0.00 | 100.00 ± 0.00 | 100.00 ± 0.00 | 98.25 ± 2.48 | 98.25 ± 2.48 |
| HSI 8 | 0.69 ± 0.02 ns | 0.74 ± 0.06 | 0.72 ± 0.04 | 0.73 ± 0.10 | 0.71 ± 0.07 | 0.77 ± 0.09 |
| VSI 9 | 6.68 ± 0.04 ns | 6.76 ± 0.01 | 6.64 ± 0.20 | 6.70 ± 0.16 | 6.65 ± 0.14 | 6.75 ± 0.09 |
| CF 10 | 1.52 ± 0.07 ns | 1.55 ± 0.07 | 1.54 ± 0.01 | 1.52 ± 0.03 | 1.55 ± 0.01 | 1.54 ± 0.03 |
1 Values are mean ± SD from triplicate groups of fish (n = 3); values in each row with different superscripts (a,b) are significantly different (p < 0.05) and the values in each row with no superscripts are non-significantly (ns) different (p < 0.05). 2 Weight gain (WG; %) = (final weight -initial weight) × 100/initial weight. 3 Specific growth rate (SGR; %/day) = (ln final weight—ln initial weight) × 100/d. 4 Feed efficiency (FE; %) = wet WG (g) × 100/dry feed intake (g). 5 FI = total feed intake (g). 6 Protein efficiency ratio (PER) =wet weight gain/protein intake. 7 Survival (SR; %) = (total fish-dead fish) × 100/total fish. 8 Hepatosomatic index (HSI; %) = (liver weight/body weight) × 100. 9 Viscerosomatic index (VSI; %) = (visceral weight/body weight) × 100. 10 Condition factor (CF) = (fish weight (g)/fish length (cm)3) × 100.
Whole body proximate composition of Nile tilapia fed six experimental diets for eight weeks (% dry matter basis) 1.
| Diets | ||||||
|---|---|---|---|---|---|---|
| CON | SSE | SSEP2 | SSEP4 | SQSE | TSE | |
| Moisture | 72.69 ± 0.35 ns | 71.88 ± 2.14 | 71.67 ± 1.37 | 71.03 ± 0.45 | 72.76 ± 0.65 | 72.66 ± 0.26 |
| Crude protein | 15.77 ± 0.22 ns | 16.20 ± 1.15 | 16.55 ± 0.81 | 16.58 ± 0.18 | 15.99 ± 0.40 | 15.87 ± 0.55 |
| Crude Lipid | 6.63 ± 0.77 ns | 6.29 ± 1.54 | 6.72 ± 0.63 | 7.39 ± 0.51 | 6.87 ± 0.67 | 6.36 ± 1.35 |
| Crude Ash | 4.56 ± 0.17 ns | 4.72 ± 0.20 | 5.08 ± 0.43 | 5.00 ± 0.32 | 4.77 ± 0.81 | 4.55 ± 0.31 |
1 Values are mean ± SD from triplicate groups of fish (n = 3) where the values in each row with no superscripts are non-significantly (ns) different (p < 0.05).
Hematological parameters of Nile tilapia fed six experimental diets for eight weeks 1.
| Diets | ||||||
|---|---|---|---|---|---|---|
| CON | SSE | SSEP2 | SSEP4 | SQSE | TSE | |
| AST 2 | 76.0 ± 4.6 ns | 77.0 ± 2.6 | 75.0 ± 2.0 | 75.0 ± 3.0 | 75.0 ± 2.0 | 74.7 ± 2.1 |
| ALT 3 | 3.0 ± 1.0 ns | 2.0 ± 0.0 | 3.0 ± 1.0 | 2.7 ± 0.6 | 2.7 ± 0.6 | 2.7 ± 0.6 |
| GLU 4 | 44.3 ± 2.3 ns | 43.0 ± 1.0 | 45.3 ± 1.5 | 44.0 ± 1.0 | 43.0 ± 1.0 | 43.0 ± 1.0 |
| TCHO 5 | 224.3 ± 0.6 ns | 224.0 ± 1.0 | 225.3 ± 1.5 | 224.3 ± 0.6 | 224.0 ± 1.7 | 225.3 ± 1.5 |
1 Values are mean ± SD from triplicate groups of fish (n = 3) where the values in each row with no superscripts are non-significantly (ns) different (p < 0.05). 2 Aspartate aminotransferase, AST (U/L). 3 Alanine aminotransferase, ALT (U/L). 4 Glucose, GLU (mg/dL). 5 Total-Cholesterol, TCHO (mg/dL).
Figure 1Non-specific immune responses of juvenile Nile tilapia fed six experimental diets in triplicate (n = 3) for eight weeks. Values represent mean ± SD (n = 3). Different letters (a,b,c) indicate a significant difference (p < 0.05).
Figure 2Cumulative survival rate of Nile tilapia fed six experimental diets in triplicate (n = 3) and challenged with Aeromonas hydrophila (1 × 106 CFU/fish) for 10 days. Different letters (a,b) indicate a significant difference (p < 0.05).